Re: Graefen M, Augustin H, Karakiewicz PI, Hammerer PG, Haese A, Palisaar J, et al. Can Predictive Models for Prostate Cancer Patients Derived in the United States of America Be Utilized in European Patients? A Validation Study of the Partin Tables. Eur Urol 2003;43(1):6-11

By Borque A.  

European Urology, Vol. 44, Iss. 3, 2003-09 ,pp. : 377-377

Elsevier

Access to resources Recommend Favorite

Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium

By Partin A.W.   Mangold L.A.   Lamm D.M.   Walsh P.C.   Epstein J.I.   Pearson J.D.  

Urology, Vol. 58, Iss. 6, 2001-12 ,pp. : 843-848

Elsevier

Access to resources Recommend Favorite

Validation of Epstein criteria of insignificant prostate cancer in Middle East patients

By Hekal Ihab   El-Tabey Nasr   Nabeeh Mohamed   El-Assmy Ahmed   El-Hameed Mohamed   Nabeeh Adel   Ibrahiem Elhousseiny  

International Urology and Nephrology, Vol. 42, Iss. 3, 2010-09 ,pp. : 667-671

Springer Publishing Company

Access to resources Recommend Favorite

Predictive factor analysis as the basis for the clinical utility of percent positive prostate biopsies in patients with intermediate-risk prostate cancer

By Yoon J.H.   Chen M.-H.   Renshaw A.A.   Richie J.P.   D'Amico A.V.  

Urology, Vol. 60, Iss. 3, 2002-09 ,pp. : 454-457

Elsevier

Access to resources Recommend Favorite

Hospital volume and surgical outcomes for elderly patients with colorectal cancer in the United States

By Dimick J.B.   Cowan J.A.   Upchurch G.R.   Colletti L.M.  

Journal of Surgical Research, Vol. 114, Iss. 1, 2003-09 ,pp. : 50-56

Elsevier

Access to resources Recommend Favorite